title: Pustular psoriasis development after initial ustekinumab administration in chronic plaque psoriasis.
authors.forename: Stamatis
authors.initials: S
authors.lastname: Gregoriou
authors.forename: Charalambos
authors.initials: C
authors.lastname: Kazakos
authors.forename: Eleftheria
authors.initials: E
authors.lastname: Christofidou
authors.forename: George
authors.initials: G
authors.lastname: Kontochristopoulos
authors.forename: George
authors.initials: G
authors.lastname: Vakis
authors.forename: Dimitrios
authors.initials: D
authors.lastname: Rigopoulos
mesh_terms: D000911:Antibodies, Monoclonal / Q000009:adverse effects* / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D002908:Chronic Disease; D005260:Female; D006801:Humans; D007155:Immunologic Factors / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D011565:Psoriasis / Q000188:drug therapy* / Q000473:pathology; D000069549:Ustekinumab
chemical_list: D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D007155:Immunologic Factors; D000069549:Ustekinumab